儿童营养不足与生长激素/胰岛素样生长因子-1相关性研究进展

doi:10.11852/zgetbjzz2020-1118

摘要/Abstract

摘要： 目前,儿童营养不足的情况在我国农村和贫困山区仍较常见,常因蛋白质与锌、铁等微量元素摄入不足,出现生长发育迟缓、低体重、贫血等现象。生长激素(GH)/胰岛素样生长因子-1(IGF-1)轴是促进儿童和青少年生长发育的主要调控因素。本文主要总结了儿童和青少年营养不足对GH/IGF-1轴的影响,以及在评估GH/IGF-1轴时考虑儿童营养状况的重要性。

关键词: 营养不足, 生长激素, 胰岛素样生长因子-1

Abstract: At present, undernutrition is still common among children and adolescents in our country, especially in remote and rural areas of the western China. Children in remote areas often suffer from inadequate intake of protein and trace elements such as zinc and iron due to economic reasons, resulting in growth retardation, low weight and anemia. The growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis is the main regulator of growth and development in children and adolescents. This review summarizes the effects of undernutrition on the GH/IGF-1 axis and discusses the importance of nutritional status of children in assessing the GH/IGF-1 axis.

Key words: undernutrition, growth hormone, insulin-like growth factor-1

中图分类号:

R153.2

张甜, 孙海玲, 张梅, 班博, 孙冰. 儿童营养不足与生长激素/胰岛素样生长因子-1相关性研究进展[J]. 中国儿童保健杂志, 2021, 29(7): 734-737.

ZHANG Tian, SUN Hai-ling, ZHANG Mei, BAN Bo, SUN Bing. Research progress on the undernutrition and growth hormone/insulin-like growth factor-1 with children[J]. Chinese Journal of Child Health Care, 2021, 29(7): 734-737.

参考文献

[1] 贾薇,曲秀芹. 2014~2018年乌鲁木齐农村中小学生营养状况分析[J]. 疾病预防控制通报, 2020,35(1):64-67.
[2] 喻艳琴,张秀秀,田薇,等. 贵州省西部燃煤型地氟病区8～14岁农村小学生营养不良和氟斑牙调查[J]. 贵州医科大学学报, 2020,45(1):13-17.
[3] 方春娥.小儿营养不良的发生原因及保健对策研究[J]. 中国医药指南, 2017,15(34):156-157.
[4] 刘精明. 我国儿童营养不良状况分析[J]. 江苏社会科学, 2019,302(1):65-74.
[5] 徐鑫,高健,张雪峰. 学龄前儿童膳食结构和营养状况研究进展[J/OL]. 全科口腔医学电子杂志, 2019,6(36):11-17.
[6] Grimberg A, DiVall SA, Polychronakos C, et al. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-1 deficiency[J]. Horm Res Paediatr, 2016,86(6):361-397.
[7] Bergan-Roller HE, Sheridan MA. The growth hormone signaling system: insights into coordinating the anabolic and catabolic actions of growth hormone[J]. Gen Comp Endocrinol, 2018,258:119-133.
[8] Papathanasiou AE, Nolen-Doerr E, Farr OM, et al. Geoffrey harris prize lecture 2018: novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans[J]. Eur J Endocrinol, 2019,180(2):R59-R71.
[9] Kosior-Korzecka U, Wojcik M, Longo V, et al. Changes in growth hormone secretion and leptin receptor mRNA expression under the influence of leptin and adrenocorticotropin in pituitary cells of early weaned ewe lambs[J]. J Physiol Pharmacol, 2019,70(4).doi:10.26402/jpp.2019.4.03.
[10] Yonezawa T, Mogi K, Li JY, et al. Negative correlation between neuropeptide Y profile in the cerebrospinal fluid and growth hormone pulses in the peripheral circulation in goats[J]. Neuroendocrinology, 2010,91(4):308-317.
[11] Poger D, Mark AE. Turning the growth hormone receptor on: evidence that hormone binding induces subunit rotation[J]. Proteins, 2010,78(5):1163-1174.
[12] Feigerlova E, Hwa V, Derr MA, et al. Current issues on molecular diagnosis of GH signaling defects[J]. Endocr Dev, 2013,24:118-127.
[13] Schneider A, Pfeifer LF, Da S NJ, et al. Effect of exogenous insulin and fasting on growth hormone receptor and IGF-I expression in the pre-ovulatory follicle of ewes[J]. Animal, 2011,5(9):1420-1425.
[14] 刘姗姗,林玮,周剑辉,等. 成纤维细胞生长因子及其在代谢性疾病中的作用与临床应用研究进展[J]. 药学进展, 2019,43(1):19-28.
[15] Grunwald T, De Luca F. Role of fibroblast growth factor 21 (FGF21) in the regulation of statural growth[J]. Curr Pediatr Rev, 2015,11(2):98-105.
[16] 黄琪,陈瑞,陈丽,等.电针激活沉默信息调节因子2相关酶1调控下丘脑抑食欲肽对肥胖大鼠代谢的影响[J].针刺研究,2019,44(4):270-275.
[17] Wit JM, de Luca F. Atypical defects resulting in growth hormone insensitivity[J]. Growth Horm IGF Res, 2016,28:57-61.
[18] Lu Y, Bradley JS, McCoski SR, et al. Reduced skeletal muscle fiber size following caloric restriction is associated with calpain-mediated proteolysis and attenuation of IGF-1 signaling[J]. Am J Physiol Regul Integr Comp Physiol, 2017,312(5):R806-R815.
[19] Bailey RL, Wang TG, Kaiser CK. Clash of the primary motivations: motivated processing of emotionally experienced content in fear appeals about obesity prevention[J]. Health Commun, 2018,33(2):111-121.
[20] Romano C, Hartman C, Privitera C, et al. Current topics in the diagnosis and management of the pediatric nonorganic feeding disorders (NOFEDs)[J]. Clin Nutr, 2015,34(2):195-200.
[21] Wang T, Liu K, Li Z, et al. Prevalence of attention deficit/hyperactivity disorder among children and adolescents in China: a systematic review and meta-analysis[J]. BMC Psychiatry, 2017,17(1):32.
[22] Bou KR, Fares N, Saliba Y, et al. The effect of methylphenidate on appetite and weight[J]. Encephale, 2017,43(6):577-581.
[23] Gurbuz F, Gurbuz BB, Celik GG, et al. Effects of methylphenidate on appetite and growth in children diagnosed with attention deficit and hyperactivity disorder[J]. J Pediatr Endocrinol Metab, 2016,29(1):85-92.
[24] Kim EK, Ndahimana D, Ishikawa-Takata K, et al. Validation of dietary reference intakes for predicting energy requirements in elementary school-age children[J]. Nutr Res Pract, 2018,12(4):336-341.
[25] Kokubo Y, Yokoyama Y, Kisara K, et al. Relationship between dietary factors and bodily iron status among Japanese collegiate elite female rhythmic gymnasts[J]. Int J Sport Nutr Exerc Metab, 2016,26(2):105-113.
[26] Chu A, Holdaway C, Varma T, et al. Lower serum zinc concentration despite higher dietary zinc intake in athletes: a systematic review and meta-analysis[J]. Sports Med, 2018,48(2):327-336.
[27] Braun H, von Andrian-Werburg J, Schanzer W, et al. Nutrition status of young elite female German football players[J]. Pediatr Exerc Sci, 2018,30(1):157-167.
[28] Shimizu Y, Mutsuzaki H, Tachibana K, et al. Investigation of the female athlete triad in Japanese elite wheelchair basketball players[J]. Medicina (Kaunas), 2019,56(1):10.
[29] Barbara M, Anna K, Agnieszka ZL. The impact of professional sports activity on GH-IGF-I axis in relation to testosterone level[J]. Am J Mens Health, 2020,14(1):1-8.
[30] Cirillo F, Lazzeroni P, Sartori C, et al. Inflammatory diseases and growth: effects on the GH-IGF axis and on growth plate[J]. Int J Mol Sci, 2017,18(9):1878.
[31] Brückner A, Werkstetter KJ, Frivolt K, et al. Partial enteral nutrition has no benefit on bone health but improves growth in paediatric patients with quiescent or mild Crohn's disease[J].Clin Nutr, 2020,39(12):3786-3796.
[32] Street ME, Volta C, Ziveri MA, et al. Changes and relationships of IGFS and IGFBPS and cytokines in coeliac disease at diagnosis and on gluten-free diet[J]. Clin Endocrinol (Oxf), 2008,68(1):22-28.
[33] Ferrante E, Giavoli C, Elli L, et al. Evaluation of GH-IGF-I axis in adult patients with coeliac disease[J]. Horm Metab Res, 2010,42(1):45-49.
[34] Kim HJ, Oh SH, Kim DY, et al. Clinical characteristics and long-term outcomes of paediatric crohn's disease: a single-centre experience[J]. J Crohns Colitis, 2017,11(2):157-164.
[35] Wong SC, Dalzell AM, Mcgrogan P, et al. The inflammatory milieu and the insulin like growth factor axis in children with inflammatory bowel disease following recombinant human growth hormone treatment[J]. J Biol Regul Homeost Agents, 2015,29(1):27-37.
[36] Shen Y, Zhang J, Zhao Y, et al. Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency:a systematic review with meta-analysis[J]. Eur J Pediatr, 2015,174(4):419-427.
[37] Binder G, Reinehr T, Ibanez L, et al. GHD diagnostics in europe and the US: an audit of national guidelines and practice[J]. Horm Res Paediatr, 2019,92(3):150-156.
[38] Katsumata N. Standardization of growth hormone and insulin-like growth factor-1 measurement[J]. Pediatr Endocrinol Rev, 2018,16(Suppl 1):28-32.
[39] Lewinski A, Smyczynska J, Stawerska R, et al. National program of severe growth hormone deficiency treatment in adults and adolescents after completion of growth promoting therapy[J]. Endokrynol Pol, 2018,69(5):468-524.
[40] Stagnaro S. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood; adult stroke risk after growth hormone treatment in childhood: first do no harm[J]. Neurology, 2015,84(15):1613-1614.